Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes ... more emphasis on the use of cystatin C for assessment of glomerular filtration rate; use of ...

A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the ... to integrate them into fracture ...

For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

People who live with chronic diseases such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), connective tissue diseases (CTD), chronic kidney disease (CKD), liver ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology ...

NKGen Biotech (NKGN) announced the oral presentation of updated Phase 1 clinical data from the Phase 1/2a trial evaluating troculeucel, ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- In a 2024 clinical practice guideline issued by the Kidney Disease ... on the use of cystatin C for assessment of glomerular filtration rate; use ...

Researchers from Florida Atlantic University argue that doctors should consider each patient's individual risk profile rather ...

In an effort to achieve a target of 80% of patients controlling the three highs and protecting kidney health within eight ...

Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed ...